Status:

RECRUITING

Personalised Health Motor and Cognitive Assistance System for RehAbilitation (PHRASE)

Lead Sponsor:

Eodyne Systems SL

Conditions:

Stroke

Stroke Rehabilitation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study is a multicentric randomized controlled trial evaluating the effectiveness of digital technology, specifically a smartphone with integrated VR-and AR-based intervention, for at-home rehabil...

Detailed Description

Stroke-induced motor and cognitive impairments often worsen after hospital discharge due to limited access to rehabilitation, creating a cycle of non-use and functional loss ("rehabilitation in vain")...

Eligibility Criteria

Inclusion

  • Patients presenting an ischemic or intracerebral haemorrhagic stroke, ≥ 3 months post-stroke.
  • Age \> 18 years old
  • Moderate to mild proximal upper limb motor impairment Medical Research Council Scale (MRC \>2).
  • ARAT: \<50, inclusive, to avoid ceiling effects while allowing room for improvement.
  • Able to sit on a chair or a wheelchair to interact with the RGS system.
  • Minimal experience with smartphone technology based on the clinician's opinion
  • Willing to participate and agree to comply with the trial scheme and procedures
  • Must sign an Informed Consent Form (ICF) indicating that they understand the purpose and the procedures of the study.

Exclusion

  • Presence of a condition or abnormality that, in the opinion of the investigator, would compromise the safety of the patient or the quality of the data.
  • Severe cognitive capabilities that prevent the execution of the study, evaluated by the MoCA \< 19 or based on the clinician's opinion.
  • Pre-stroke history of upper limb motor disability.
  • Unable to use the RGS independently, according to the clinician's observations, and needing more support from a caregiver to use the RGS.

Key Trial Info

Start Date :

February 21 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2026

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT06885502

Start Date

February 21 2025

End Date

June 30 2026

Last Update

January 6 2026

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

RoNeuro Institute for Neurological Research and Diagnostics

Cluj-Napoca, Romania, 400354

2

Hospital Universitari Joan XXIII de Tarragona

Tarragona, Spain, 43005